Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Lymphoid progenitors as candidate cancer stem cells in AML: New perspectives.
Cell Cycle 6, 543-545 (2007)
Mouse models have demonstrated that both hematopoietic stem cells (HSCs) as well as downstream myeloid progenitors can be targets of transformation in AML. We recently showed in a murine model of the CALM/AF10 fusion gene positive leukemia, that progenitors with lymphoid characteristics can be leukemic stem cell (LSC) candidates in AML. We could demonstrate that the LSC candidate in the CALM/AF10 murine model was positive for the lymphoid associated surface antigen B220, which was not expressed by the leukemic bulk or the normal HSC pool. This offers the intriguing possibility to target the LSCs with antibodies that spare the normal stem cell.
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
CALM/AF10; leukemic stem cells; AML; targeted therapy
ISSN (print) / ISBN
1538-4101
e-ISSN
1551-4005
Zeitschrift
Cell Cycle
Quellenangaben
Band: 6,
Heft: 5,
Seiten: 543-545
Verlag
Landes Bioscience
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed